These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9324824)

  • 41. Thromboembolic events secondary to estrogen therapy.
    Lee JR
    Am Fam Physician; 1998 May; 57(9):2071. PubMed ID: 9606299
    [No Abstract]   [Full Text] [Related]  

  • 42. [Conventional hormonal replacement therapy in treatment of osteoporosis].
    Meczekalski B; Czyzyk A
    Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Risk of thrombosis with oral contraceptives].
    Kuhl H
    Zentralbl Gynakol; 1996; 118(9):485-6. PubMed ID: 8992815
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hormone replacement therapy in menopause, hemostasis and thromboembolic risk].
    Levesque H; Cailleux N; Courtois H
    J Mal Vasc; 1994; 19(2):93-7. PubMed ID: 8077869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postmenopausal hormone therapy in clinical perspective.
    Hodis HN; Mack WJ
    Menopause; 2007; 14(5):944-57. PubMed ID: 17353803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
    Canonico M; Straczek C; Oger E; Plu-Bureau G; Scarabin PY
    Maturitas; 2006 Jul; 54(4):372-9. PubMed ID: 16730142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Only two secure indications left. Changing one's view of hormone replacement therapy].
    Fath R
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2236. PubMed ID: 14608994
    [No Abstract]   [Full Text] [Related]  

  • 50. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].
    Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037
    [No Abstract]   [Full Text] [Related]  

  • 51. Estrogen replacement therapy and the risk of venous thrombosis.
    Devor M; Barrett-Connor E; Renvall M; Feigal D; Ramsdell J
    Am J Med; 1992 Mar; 92(3):275-82. PubMed ID: 1546726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [P-pills, hormonal substitution and surgery--yes, or no?].
    Maltau JM; Oian P
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):934. PubMed ID: 7709380
    [No Abstract]   [Full Text] [Related]  

  • 53. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of venous thrombosis with hormone replacement therapy.
    Scarabin PY
    Lancet; 1996 Dec; 348(9042):1668. PubMed ID: 8962022
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hormonal replacement therapy in menopause and cancer risk. An update].
    La Vecchia C; Franceschi S
    Minerva Ginecol; 2003 Jun; 55(3):217-9. PubMed ID: 14581867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.